New drug trial offers hope for advanced lung cancer patients
NCT ID NCT07003321
Summary
This study is testing an experimental drug called HRS-4508 for people with advanced non-small cell lung cancer that has spread or can't be removed by surgery. The trial will enroll 120 patients whose cancer has continued to grow despite standard treatments. Researchers want to see if HRS-4508 can shrink tumors and control the cancer while monitoring for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Contact
Conditions
Explore the condition pages connected to this study.